A
Abhishek Deshpande
Researcher at Cleveland Clinic
Publications - 169
Citations - 4455
Abhishek Deshpande is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Clostridium difficile & Internal medicine. The author has an hindex of 34, co-authored 141 publications receiving 3675 citations. Previous affiliations of Abhishek Deshpande include Case Western Reserve University & Cleveland Clinic Lerner Research Institute.
Papers
More filters
Journal ArticleDOI
Community-associated Clostridium difficile infection and antibiotics: a meta-analysis
Abhishek Deshpande,Vinay Pasupuleti,Priyaleela Thota,Chaitanya Pant,David D. K. Rolston,Thomas J. Sferra,Adrian V. Hernandez,Curtis J. Donskey,Curtis J. Donskey +8 more
TL;DR: Antibiotic exposure was an important risk factor for CA-CDI, but the risk was different amongst different antibiotic classes, and the classes of antibiotics posing the greatest risk were determined.
Journal ArticleDOI
Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis of randomized controlled trials
Faustino R. Pérez-López,Vinay Pasupuleti,Edward Mezones-Holguín,Vicente A. Benites-Zapata,Priyaleela Thota,Abhishek Deshpande,Adrian V. Hernandez,Adrian V. Hernandez +7 more
TL;DR: Vitamin D supplementation during pregnancy was associated with increased circulating 25(OH)D levels, birth weight, and birth length, and was not associated with other maternal and neonatal outcomes.
Journal ArticleDOI
Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis.
Abhishek Deshpande,Vinay Pasupuleti,Priyaleela Thota,Chaitanya Pant,David D. K. Rolston,Adrian V. Hernandez,Curtis J. Donskey,Thomas G. Fraser +7 more
TL;DR: Identification of modifiable risk factors and judicious use of antibiotics and PPI can play an important role in the prevention of rCDI.
Journal ArticleDOI
Association Between Proton Pump Inhibitor Therapy and Clostridium difficile Infection in a Meta-Analysis
Abhishek Deshpande,Chaitanya Pant,Vinay Pasupuleti,David D. K. Rolston,Anil Jain,Narayan Deshpande,Priyaleela Thota,Thomas J. Sferra,Adrian V. Hernandez +8 more
TL;DR: PPI therapy is associated with a 2-fold increase in risk for CDI, and this association remained after subgroup and sensitivity analyses, although significant heterogeneity persisted among studies.
Journal ArticleDOI
Pulmonary hypertension: An important predictor of outcomes in patients undergoing non-cardiac surgery
TL;DR: In addition to the traditionally known risk factors for outcomes after NCS such as coronary artery disease, diabetes mellitus, chronic renal insufficiency, American Society of Anesthesiology class, the presence of underlying PH can have a significant negative impact on perioperative outcomes.